Skip to main content
    E

    Envoy Medical Inc. (COCH)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $6.92
    +0.18 (+2.75%)

    Market Cap: $52.16M

    Last updated: Nov 17, 2026 at 10:59 AM ET

    Envoy Medical Inc. (COCH) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Envoy Medical (COCH) to earn -$2.62 per share in the fiscal year ending Dec 31, 2026, on revenue of $237000. Of 3 analysts, 3 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$2.44.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 3 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.

    RatingAnalystsShare
    Strong Buy00.0%
    Buy3100.0%
    Hold00.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    3

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 15.3%.

    Fiscal year ending Dec 31, 2026
    -$2.62
    EPS consensus, revenue $237000
    Fiscal year ending Dec 31, 2027
    -$2.44
    EPS consensus, revenue $273330
    Next report
    Mar 22, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$2.62-$2.66 to -$2.603$237000$200000 to $3000003
    Dec 31, 2027-$2.44-$2.70 to -$2.253$273330$200000 to $4000003

    Quarterly Estimates

    The EPS consensus rises from -$0.71 for the quarter ending Dec 31, 2026 to -$0.61 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.71-$0.88 to -$0.635$88403$58800 to $1050005
    Mar 31, 2027-$0.61-$0.66 to -$0.533$100000$100000 to $1000003

    Estimate Revisions

    No EPS estimate for the 2 periods below was revised in the last 30 days.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202600
    Quarter ending Mar 31, 202700

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$3.10.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$2.62-$2.87-$2.87-$2.95-$3.10N/A
    Fiscal year ending Dec 31, 2027-$2.44-$2.35-$2.37-$2.20-$2.25N/A
    Quarter ending Mar 31, 2027-$0.61-$0.65-$0.63-$0.65-$0.65N/A

    Frequently Asked Questions About COCH

    What is the COCH stock forecast?

    Consensus analyst estimates put Envoy Medical's EPS at -$2.62 for the fiscal year ending Dec 31, 2026, on revenue of $237000. The consensus rating from 3 analysts is Buy.

    How do analysts rate COCH stock?

    Of 3 analysts covering Envoy Medical, 0 rate it Strong Buy, 3 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from COCH next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$2.62, with estimates from -$2.66 to -$2.60 from 3 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$2.44, with estimates from -$2.70 to -$2.25 from 3 analysts.

    What revenue do analysts expect from Envoy Medical next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $237000, with estimates from $200000 to $300000. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $273330, with estimates from $200000 to $400000.

    How many analysts cover COCH?

    3 analysts rate Envoy Medical stock, and 3 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.